945562-16-3

Upstream product

• 945561-97-7 ethyl (3-chloro-4-{4-(ethyloxy)-1,3-dioxo-9-[(phenylmethyl)oxy]-1,3-dihydro-2H-benzo[f]isoindol-2-yl}phenyl)acetate 
• 945561-70-6 ethyl [3-chloro-4-(4,9-dihydroxy-1,3-dioxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetate 
• 75-03-6 ethyl iodide 

Downstream Products

• 1004514-41-3 ethyl (3-chloro-4-{4-(ethyloxy)-1,3-dioxo-9-[(2,2,2-trifluoroethyl)oxy]-1,3-dihydro-2H-benzo[f]isoindol-2-yl}phenyl)acetate 
• 1004513-88-5 ethyl {3-chloro-4-[4-[(2,2-difluoroethyl)oxy]-9-(ethyloxy)-1,3-dioxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]phenyl}acetate 

Relevant academic research and scientific papers

BENZO [F] ISOINDOLES AS EP4 RECEPTOR AGONISTS

The present invention relates to naphthalene derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine.

NAPHTHALENE DERIVATIVES USED AS EP4 RECEPTOR AGONISTS

A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1 R2 R3, X and Y are as defined in the specification; a process fo preparing such compounds; a pharmaceutical composition comprising

BENZOISOINDOLE DERIVATIVES FOR THE TREATMENT OF PAIN

A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1, R2, R3, X and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprisi